Trends in gabapentin and baclofen exposures reported to U.S. poison centers
(2019). Trends in gabapentin and baclofen exposures reported to U.S. poison centers. Clinical Toxicology. Ahead of Print.
Related Articles
GLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
TikTok points researcher toward signal of benefit
Patient Phenotypes Within the Clinical Program of an IL-23 Inhibitor for PsA | RheumNow
Watch rheumatologist Dr. Alexis Ogdie and rheumatologist and dermatologist Dr. Saakshi Khattri discuss a new analysis of patient phenotypes in PsA from clinical trials of…
GLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
TikTok points researcher toward signal of benefit
Patient Phenotypes Within the Clinical Program of an IL-23 Inhibitor for PsA | RheumNow
Watch rheumatologist Dr. Alexis Ogdie and rheumatologist and dermatologist Dr. Saakshi Khattri discuss a new analysis of patient phenotypes in PsA from clinical trials of…
Daily Eular 2025 Recap Day 3 | RheumNow
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the third day of EULAR 2025. Join us live as we break down…
Psoriatic Arthritis at Risk for Interstitial Lung Disease | RheumNow
A TriNetX EHR study shows that psoriatic arthritis, but not psoriasis, patients are at increased risk for interstitial lung disease (ILD).